On September 17, 2018 hopes were high regarding the clarification of the regulatory framework as well as a potential decision or ambitions by the FDA to stimulate further discussion regarding microbiome-based products, as the agency […]
Global demand exists for new ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance. A scientific paper published in European Journal of Public Health reports that those who take probiotics as […]
An accepted component of scientific investigation is the review process both prior to publication and afterwards. Since there are no perfect studies, there will always be room for criticism and praise of any given study. […]
More than 1,000 species of bacteria have been identified in the human gut, and understanding this incredibly diverse “microbiome” that can greatly impact health and disease is a hot topic in scientific research. Because bacteria […]
Microbiome-focused companies have many different areas of interest—but what they have in common is a drive to learn more about the conditions and activities of bacteria and other microorganisms. Martha Carlin, CEO and co-founder of […]
Over the last several years, there’s been growing scientific and public interest in the role of microorganisms in the maintenance of overall health and prevention and treatment of disease. Today, more so than ever before, […]
Our focus turns to biofilms and with the expertise of Scioto Biosciences, a preclinical stage company devoted to having a transformative impact on the delivery of microbiome therapeutics; we discuss their role, characteristics and future potential […]
The IPC conference was co-hosted 18-21st June with the probiotics in foods and feeds regulatory workshop, SOMED (Society for Microbial Ecology and Diseases), BAMP (Bacteriocins and Antimicrobial Peptides symposium) and the Animal Health Symposium. This […]
Four new studies reported at the Alzheimer’s Association International Conference (AAIC) 2018 in Chicago investigated how the digestive system, including gut and liver functions, may be related to changes in the brain, and to brain […]
Microbiome Times got in touch with Dr Edward Green, CEO of CHAIN Biotechology Ltd – a UK based microbiome Company focused on the development and commercialization of microbial technology for the production and delivery of biotherapeutics. Dr Edward […]